Rein Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Rein Therapeutics, Inc. has filed 525 SEC EDGAR filings since 03 Dec 2007

SEC filing history

Showing 301-325 of 522 matching filings.

Per page
25
Current page
13
SC 13G/A File 005-90032

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90032

13G AMENDED ANNUAL FILING (ALRN)

Filing date
03 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38130

8-K

Filing date
30 Dec 2019
Reporting date
27 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Nov 2019
Reporting date
14 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90032

SC 13G/A filing

Filing date
12 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90032

13G - AMENDED MONTHLY FILING - ALRN

Filing date
08 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38130

ALRN-Q3-20190930

Filing date
07 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
8-K File 001-38130

8-K

Filing date
30 Sep 2019
Reporting date
28 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38130

8-K

Filing date
09 Sep 2019
Reporting date
04 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2019
Reporting date
04 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Sep 2019
Reporting date
30 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Sep 2019
Reporting date
29 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Aug 2019
Reporting date
16 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Aug 2019
Reporting date
13 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90032

SC 13D/A

Filing date
13 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-231143

EFFECT filing

Filing date
16 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-226650

EFFECT filing

Filing date
15 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .